150 related articles for article (PubMed ID: 32067504)
21. Cutaneous iontophoresis of μ-conotoxin CnIIIC-A potent Na
Del Río-Sancho S; Cros C; Coutaz B; Cuendet M; Kalia YN
Int J Pharm; 2017 Feb; 518(1-2):59-65. PubMed ID: 28034736
[TBL] [Abstract][Full Text] [Related]
22. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
23. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
Marro D; Kalia YN; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
[TBL] [Abstract][Full Text] [Related]
24. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches.
de Sá FAP; Andrade JFM; Miranda TC; Cunha-Filho M; Gelfuso GM; Lapteva M; Kalia YN; Gratieri T
Int J Pharm; 2023 Dec; 648():123617. PubMed ID: 37977289
[TBL] [Abstract][Full Text] [Related]
25. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility.
Abla N; Geiser L; Mirgaldi M; Naik A; Veuthey JL; Guy RH; Kalia YN
J Pharm Sci; 2005 Dec; 94(12):2667-75. PubMed ID: 16258982
[TBL] [Abstract][Full Text] [Related]
26. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF
Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720
[TBL] [Abstract][Full Text] [Related]
27. Optimization of aminolevulinic acid delivery by iontophoresis.
Lopez RF; Bentley MV; Begoña Delgado-Charro M; Guy RH
J Control Release; 2003 Feb; 88(1):65-70. PubMed ID: 12586504
[TBL] [Abstract][Full Text] [Related]
28. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.
Gratieri T; Zarhloule R; Dubey S; Kalia YN
Int J Pharm; 2021 Jun; 602():120607. PubMed ID: 33862130
[TBL] [Abstract][Full Text] [Related]
29. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles.
Bath BD; Scott ER; Phipps JB; White HS
J Pharm Sci; 2000 Dec; 89(12):1537-49. PubMed ID: 11042601
[TBL] [Abstract][Full Text] [Related]
30. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
Saepang K; Li SK; Chantasart D
Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
[TBL] [Abstract][Full Text] [Related]
31. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.
Lopez RF; Bentley MV; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Mar; 18(3):311-5. PubMed ID: 11442270
[TBL] [Abstract][Full Text] [Related]
32. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity.
Taveira SF; Nomizo A; Lopez RF
J Control Release; 2009 Feb; 134(1):35-40. PubMed ID: 19047006
[TBL] [Abstract][Full Text] [Related]
33. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
34. Controlled Iontophoretic Delivery
Singhal M; Merino V; Rosini M; Cavalli A; Kalia YN
Mol Pharm; 2019 Aug; 16(8):3460-3468. PubMed ID: 31241959
[TBL] [Abstract][Full Text] [Related]
35. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
36. Transdermal iontophoresis: modulation of electroosmosis by polypeptide.
Hirvonen J; Guy RH
J Control Release; 1998 Jan; 50(1-3):283-9. PubMed ID: 9685895
[TBL] [Abstract][Full Text] [Related]
37. Passive and iontophoretic transdermal penetration of chlorpromazine.
Alvarez-Figueroa MJ; González-Aramundiz JV
Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
[TBL] [Abstract][Full Text] [Related]
38. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
Schuetz YB; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
[TBL] [Abstract][Full Text] [Related]
39. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro.
Lopez RF; Bentley MV; Delgado-Charro MB; Salomon D; van den Bergh H; Lange N; Guy RH
Photochem Photobiol; 2003 Mar; 77(3):304-8. PubMed ID: 12685659
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
